Skip to main content
Hit enter to search or ESC to close
Close Search
search
Menu
Newsfeed
Shop
Resources
twitter
facebook
linkedin
youtube
instagram
tiktok
Patients
Understanding NF
Neurofibromatosis Type 1
NF2
-Related Schwannomatosis
Schwannomatosis
Find a Doctor
NF Treatments
NF Registry
Resource Center
Educational Events
Patient Engagement
Clinical Trials
Healthcare Professionals
Diagnostic Criteria
NF Clinic Network (NFCN)
Conferences & Education
Partnerships
Clinical Trials Pipeline
Researchers
Funding Opportunities
Conferences & Education
Research Tools & Resources
Leading Minds in NF Research
Pharma
For Pharma & Biotech
Industry Partnerships
Our Impact
Our Mission
Our Impact
Our Portfolio
About CTF
Our Strategy
Take Action
Ways to Give
Events & Fundraisers
Raise Awareness
Advocacy
Volunteer
Share Your Story
search
Donate
Tag
approved treatments
NF1
Pharma
Science & Research
Top Story
Top Story EU
IT’S A GO! NF’s NEXT BIG WIN!
Search
Search
Recent Posts
NF Awareness Month National Billboard Campaign
CTF Featured in Clinical Research News for Rethinking the Role of Nonprofits in R&D
Story of NF: Michael M.
Children’s Tumor Foundation 2024 Impact Report
CTF CEO Annette Bakker Moderates Panel at World Orphan Drug Congress 2025
Recent Comments
No comments to show.
Close Menu
Donate
Patients
Understanding NF
Neurofibromatosis Type 1
NF2
-Related Schwannomatosis
Schwannomatosis
Find a Doctor
NF Treatments
NF Registry
Resource Center
Educational Events
Patient Engagement
Clinical Trials
Healthcare Professionals
Diagnostic Criteria
NF Clinic Network (NFCN)
Conferences & Education
Partnerships
Clinical Trials Pipeline
Researchers
Funding Opportunities
Conferences & Education
Research Tools & Resources
Leading Minds in NF Research
Pharma
For Pharma & Biotech
Industry Partnerships
Our Impact
Our Mission
Our Impact
Our Portfolio
About CTF
Our Strategy
Take Action
Ways to Give
Events & Fundraisers
Raise Awareness
Advocacy
Volunteer
Share Your Story
Newsfeed
Shop
Resources
